INTRAVITREAL RANIBIZUMAB FOR CHOROIDAL NEOVASCULARIZATION IN ANGIOID STREAKS: Four-Year Follow-up.

@article{Tilleul2016INTRAVITREALRF,
  title={INTRAVITREAL RANIBIZUMAB FOR CHOROIDAL NEOVASCULARIZATION IN ANGIOID STREAKS: Four-Year Follow-up.},
  author={Julien Tilleul and Gerard Mimoun and Giuseppe Querques and Nathalie Puche and Jennyfer Zerbib and Franck Lalloum and Mayer Srour and Eric H Souied},
  journal={Retina},
  year={2016},
  volume={36 3},
  pages={483-91}
}
PURPOSE To analyze retrospectively the efficacy of intravitreal ranibizumab injections for the management of choroidal neovascularization in patients with angioid streaks over a long term. METHODS In this "nonrandomized," double-center, retrospective, interventional case series, a consecutive series of patients affected with choroidal neovascularization associated with angioid streaks were treated with intravitreal ranibizumab injections (0.5 mg/0.05 mL). Best-corrected visual acuity, fundus… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 2 times. VIEW TWEETS